Patent details

EP2812443 Title: CD47 ANTIBODIES AND METHODS OF USE THEREOF

Basic Information

Publication number:
EP2812443
PCT Application Number:
US2013024995
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP137469649
PCT Publication Number:
WO2013119714
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CD47 ANTIBODIES AND METHODS OF USE THEREOF
French Title of Invention:
ANTICORPS ANTI-CD47 ET LEURS MÉTHODES D'UTILISATION
German Title of Invention:
CD47-ANTIKÖRPER UND VERFAHREN ZUR VERWENDUNG DAVON
SPC Number:

Dates

Filing date:
06/02/2013
Grant date:
29/05/2019
EP Publication Date:
17/12/2014
PCT Publication Date:
15/08/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/05/2019
EP B1 Publication Date:
29/05/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
06/02/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/07/2024
 
 

Name:
Inhibrx Biosciences, Inc.
Address:
11025 N. Torrey Pines Road, Suite 140, CA 92037, La Jolla. , United States (US)

History of Owners

From:
22/05/2019
To:
05/07/2024

Name:
Inhibrx, Inc.
Address:
11025 N. Torrey Pines Road, Suite 200, La Jolla, CA 92037, United States (US)

Agent

Name:
VALIPAT
From:
25/07/2019
Address:
Uitbreidingstraat 72-5, 2600, Antwerp, Belgium (BE)
To:

Inventor

1

Name:
ECKELMAN, Brendan
Address:
United States (US)

2

Name:
RAZAI, Amir
Address:
United States (US)

3

Name:
JONES, Kyle
Address:
United States (US)

4

Name:
NGUY, Peter, L.
Address:
United States (US)

5

Name:
TIMMER, John
Address:
United States (US)

6

Name:
DEVERAUX, Quinn
Address:
United States (US)

Priority

1

Priority Number:
201261595216 P
Priority Date:
06/02/2012
Priority Country:
United States (US)

2

Priority Number:
201261659752 P
Priority Date:
14/06/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; C07K 16/28; C12P 21/08;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2024/10
Publication date:
06/08/2024
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
201922
Publication date:
29/05/2019
Description:
Grant (B1)

2

Issue number:
201924
Publication date:
12/06/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

Deed

Power of attorney

Change Kind/ Decision Type:
Assignment
Deed Number:
RC20190000286A
Date Registered:
25/07/2019
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
VALIPAT
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Removed Pledgee

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20240000298A
Date Registered:
05/07/2024
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Inhibrx Biosciences, Inc.
Address:
11025 N. Torrey Pines Road, Suite 140, CA 92037, La Jolla. , United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
01/09/2025
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
29/01/2024
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
25/07/2019 Request For Change 2
06/08/2019 Outgoing Correspondence 1
05/07/2024 Request For Change 61
08/07/2024 Outgoing Correspondence 1